One Bio logo

ONBI - One Bio Share Price

$0.028 0.0  0.0%

Last Trade - 23/07/20

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £182k
Enterprise Value £9.45m
Revenue £38.8m
Position in Universe th / 6362
Bullish
Bearish
Unlock ONBI Revenue
Momentum
Relative Strength (%)
1m -18.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2005 2006 2007 2008 2009 2010 2011E 2012E CAGR / Avg
0.000 0.21 0.14 10.4 22.1 52.3 +298.7%
-4.2 +44.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2011, ONE Bio Corp revenues increased 4% to $39M. Net income increased 4% to $6.2M. Revenues reflect Organic Products segment increase of 32% to $6.2M, Herbal and Chemical Extracts segment increase of 25% to $6.1M, Asia segment increase of 28% to $12.3M. Net income also reflects Organic Products segment income increase of 21% to $2M, Financing segment income increase of 38% to $202K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ONBI Revenue Unlock ONBI Revenue

Net Income

ONBI Net Income Unlock ONBI Revenue

Normalised EPS

ONBI Normalised EPS Unlock ONBI Revenue

PE Ratio Range

ONBI PE Ratio Range Unlock ONBI Revenue

Dividend Yield Range

ONBI Dividend Yield Range Unlock ONBI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ONBI EPS Forecasts Unlock ONBI Revenue
Profile Summary

ONE Bio, Corp. (ONE), formerly ONE Holdings, Corp. is a bio-engineering company that utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. Its key products include Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. Its operations are divided into two principal complementary business units that focus on producing chemical and herbal extracts (CHE business unit) and organic products utilizing green processes (OP business unit).

Directors
Last Annual December 31st, 2010
Last Interim September 30th, 2011
Incorporated June 30, 2000
Public Since March 31, 2008
No. of Shareholders: n/a
No. of Employees: 358
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange OTC Markets Group
Shares in Issue 8,480,682
Free Float (0.0%)
Eligible for
ISAs
SIPPs
33180
View larger map
+
Address 20807 Biscayne Blvd Ste 203, AVENTURA, 33180, United States
Web
Phone +1 305 3288662
Contact ()
Auditors Jewett, Schwartz, Wolfe & Associates
ONBI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ONBI
Upcoming Events for ONBI
Frequently Asked Questions for One Bio
What is the One Bio share price?

As of 23/07/20, shares in One Bio are trading at $0.028, giving the company a market capitalisation of £182k. This share price information is delayed by 15 minutes.

How has the One Bio share price performed this year?

Shares in One Bio are currently trading at $0.028 and the price has moved by -71.77% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the One Bio price has moved by -74.17% over the past year.

What are the analyst and broker recommendations for One Bio?

There are no analysts currently covering One Bio.

When will One Bio next release its financial results?

One Bio is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2012-09-30
What is the One Bio dividend yield?

One Bio does not currently pay a dividend.

Does One Bio pay a dividend?

One Bio does not currently pay a dividend.

When does One Bio next pay dividends?

One Bio does not currently pay a dividend.

How do I buy One Bio shares?

To buy shares in One Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of One Bio?

Shares in One Bio are currently trading at $0.028, giving the company a market capitalisation of £182k.

Where are One Bio shares listed? Where are One Bio shares listed?

Here are the trading details for One Bio:

Country of listing: United States
Exchange: OTC
Ticker Symbol: ONBI
What kind of share is One Bio?

We were not able to load our ranking data for One Bio

Is there a One Bio share price forecast 2020?

We were not able to load any forecast data for One Bio.

How can I tell whether the One Bio share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like One Bio. Over the past six months, the relative strength of its shares against the market has been -27.86%. At the current price of $0.028, shares in One Bio are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the One Bio PE Ratio?

The One Bio PE ratio based on its reported earnings over the past 12 months is 0.02. The shares are currently trading at $0.028.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of One Bio?

One Bio's management team is headed by:

Michael Weingarten - CHM
Marius Silvasan - CEO
Qingsheng Fan - IND
James Fernandes - IND
Min Zhao - CEX
Cris Neely - CFO
Frank Klees - IND
John Perkins - IND
Jan Koe - IND
Who are the major shareholders of One Bio?

Here are the top five shareholders of One Bio based on the size of their shareholding:

Similar to ONBI
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.